nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—CYP2B6—Sorafenib—thyroid cancer	0.204	0.383	CbGbCtD
Thiotepa—CYP2B6—Doxorubicin—thyroid cancer	0.124	0.232	CbGbCtD
Thiotepa—CYP3A4—Vandetanib—thyroid cancer	0.104	0.195	CbGbCtD
Thiotepa—CYP3A4—Sorafenib—thyroid cancer	0.0625	0.118	CbGbCtD
Thiotepa—CYP3A4—Doxorubicin—thyroid cancer	0.0379	0.0714	CbGbCtD
Thiotepa—Anaemia—Sorafenib—thyroid cancer	0.000874	0.00186	CcSEcCtD
Thiotepa—Oliguria—Epirubicin—thyroid cancer	0.000867	0.00185	CcSEcCtD
Thiotepa—Neoplasm malignant—Doxorubicin—thyroid cancer	0.000866	0.00185	CcSEcCtD
Thiotepa—Hyperuricaemia—Epirubicin—thyroid cancer	0.000862	0.00184	CcSEcCtD
Thiotepa—Delirium—Doxorubicin—thyroid cancer	0.00086	0.00183	CcSEcCtD
Thiotepa—Extravasation—Doxorubicin—thyroid cancer	0.000848	0.00181	CcSEcCtD
Thiotepa—Leukopenia—Sorafenib—thyroid cancer	0.000846	0.00181	CcSEcCtD
Thiotepa—Blood bilirubin increased—Epirubicin—thyroid cancer	0.000845	0.0018	CcSEcCtD
Thiotepa—Amenorrhoea—Doxorubicin—thyroid cancer	0.000842	0.0018	CcSEcCtD
Thiotepa—Cough—Sorafenib—thyroid cancer	0.000825	0.00176	CcSEcCtD
Thiotepa—Asthenia—Vandetanib—thyroid cancer	0.000821	0.00175	CcSEcCtD
Thiotepa—Skin discolouration—Doxorubicin—thyroid cancer	0.000819	0.00175	CcSEcCtD
Thiotepa—Hypertension—Sorafenib—thyroid cancer	0.000816	0.00174	CcSEcCtD
Thiotepa—Blood uric acid increased—Epirubicin—thyroid cancer	0.000814	0.00174	CcSEcCtD
Thiotepa—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.000813	0.00174	CcSEcCtD
Thiotepa—Pruritus—Vandetanib—thyroid cancer	0.000809	0.00173	CcSEcCtD
Thiotepa—Myalgia—Sorafenib—thyroid cancer	0.000805	0.00172	CcSEcCtD
Thiotepa—Arthralgia—Sorafenib—thyroid cancer	0.000805	0.00172	CcSEcCtD
Thiotepa—Oliguria—Doxorubicin—thyroid cancer	0.000803	0.00171	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000799	0.00171	CcSEcCtD
Thiotepa—Hyperuricaemia—Doxorubicin—thyroid cancer	0.000797	0.0017	CcSEcCtD
Thiotepa—Dermatitis contact—Epirubicin—thyroid cancer	0.00079	0.00169	CcSEcCtD
Thiotepa—Diarrhoea—Vandetanib—thyroid cancer	0.000783	0.00167	CcSEcCtD
Thiotepa—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.000782	0.00167	CcSEcCtD
Thiotepa—Cystitis noninfective—Epirubicin—thyroid cancer	0.000781	0.00167	CcSEcCtD
Thiotepa—Cystitis—Epirubicin—thyroid cancer	0.000772	0.00165	CcSEcCtD
Thiotepa—Colitis—Epirubicin—thyroid cancer	0.000767	0.00164	CcSEcCtD
Thiotepa—Infection—Sorafenib—thyroid cancer	0.000767	0.00164	CcSEcCtD
Thiotepa—Skin exfoliation—Epirubicin—thyroid cancer	0.000763	0.00163	CcSEcCtD
Thiotepa—Fluid retention—Epirubicin—thyroid cancer	0.000759	0.00162	CcSEcCtD
Thiotepa—Nervous system disorder—Sorafenib—thyroid cancer	0.000757	0.00161	CcSEcCtD
Thiotepa—Dizziness—Vandetanib—thyroid cancer	0.000756	0.00161	CcSEcCtD
Thiotepa—Thrombocytopenia—Sorafenib—thyroid cancer	0.000756	0.00161	CcSEcCtD
Thiotepa—Blood urea increased—Epirubicin—thyroid cancer	0.000755	0.00161	CcSEcCtD
Thiotepa—Blood uric acid increased—Doxorubicin—thyroid cancer	0.000753	0.00161	CcSEcCtD
Thiotepa—Skin disorder—Sorafenib—thyroid cancer	0.00075	0.0016	CcSEcCtD
Thiotepa—Anorexia—Sorafenib—thyroid cancer	0.000736	0.00157	CcSEcCtD
Thiotepa—Dermatitis contact—Doxorubicin—thyroid cancer	0.000731	0.00156	CcSEcCtD
Thiotepa—Oesophagitis—Epirubicin—thyroid cancer	0.00073	0.00156	CcSEcCtD
Thiotepa—Vomiting—Vandetanib—thyroid cancer	0.000727	0.00155	CcSEcCtD
Thiotepa—Bladder pain—Epirubicin—thyroid cancer	0.000723	0.00154	CcSEcCtD
Thiotepa—Cystitis noninfective—Doxorubicin—thyroid cancer	0.000722	0.00154	CcSEcCtD
Thiotepa—Rash—Vandetanib—thyroid cancer	0.000721	0.00154	CcSEcCtD
Thiotepa—Dermatitis—Vandetanib—thyroid cancer	0.000721	0.00154	CcSEcCtD
Thiotepa—Headache—Vandetanib—thyroid cancer	0.000717	0.00153	CcSEcCtD
Thiotepa—Cystitis—Doxorubicin—thyroid cancer	0.000714	0.00152	CcSEcCtD
Thiotepa—Pulmonary oedema—Epirubicin—thyroid cancer	0.000711	0.00152	CcSEcCtD
Thiotepa—Colitis—Doxorubicin—thyroid cancer	0.00071	0.00152	CcSEcCtD
Thiotepa—Skin exfoliation—Doxorubicin—thyroid cancer	0.000706	0.00151	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000703	0.0015	CcSEcCtD
Thiotepa—Fluid retention—Doxorubicin—thyroid cancer	0.000702	0.0015	CcSEcCtD
Thiotepa—Blood urea increased—Doxorubicin—thyroid cancer	0.000698	0.00149	CcSEcCtD
Thiotepa—Sepsis—Epirubicin—thyroid cancer	0.000694	0.00148	CcSEcCtD
Thiotepa—Nausea—Vandetanib—thyroid cancer	0.000679	0.00145	CcSEcCtD
Thiotepa—Dyspepsia—Sorafenib—thyroid cancer	0.000679	0.00145	CcSEcCtD
Thiotepa—Oesophagitis—Doxorubicin—thyroid cancer	0.000676	0.00144	CcSEcCtD
Thiotepa—Decreased appetite—Sorafenib—thyroid cancer	0.000671	0.00143	CcSEcCtD
Thiotepa—Bladder pain—Doxorubicin—thyroid cancer	0.000669	0.00143	CcSEcCtD
Thiotepa—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000667	0.00142	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000666	0.00142	CcSEcCtD
Thiotepa—Fatigue—Sorafenib—thyroid cancer	0.000665	0.00142	CcSEcCtD
Thiotepa—Pain—Sorafenib—thyroid cancer	0.00066	0.00141	CcSEcCtD
Thiotepa—Constipation—Sorafenib—thyroid cancer	0.00066	0.00141	CcSEcCtD
Thiotepa—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000658	0.0014	CcSEcCtD
Thiotepa—Hepatic failure—Epirubicin—thyroid cancer	0.000646	0.00138	CcSEcCtD
Thiotepa—Sepsis—Doxorubicin—thyroid cancer	0.000642	0.00137	CcSEcCtD
Thiotepa—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000631	0.00135	CcSEcCtD
Thiotepa—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000617	0.00132	CcSEcCtD
Thiotepa—Urticaria—Sorafenib—thyroid cancer	0.000613	0.00131	CcSEcCtD
Thiotepa—Abdominal pain—Sorafenib—thyroid cancer	0.00061	0.0013	CcSEcCtD
Thiotepa—Body temperature increased—Sorafenib—thyroid cancer	0.00061	0.0013	CcSEcCtD
Thiotepa—Hepatic failure—Doxorubicin—thyroid cancer	0.000597	0.00127	CcSEcCtD
Thiotepa—Cardiac failure—Epirubicin—thyroid cancer	0.000595	0.00127	CcSEcCtD
Thiotepa—Hypersensitivity—Sorafenib—thyroid cancer	0.000569	0.00121	CcSEcCtD
Thiotepa—Asthenia—Sorafenib—thyroid cancer	0.000554	0.00118	CcSEcCtD
Thiotepa—Cardiac arrest—Epirubicin—thyroid cancer	0.000552	0.00118	CcSEcCtD
Thiotepa—Cardiac failure—Doxorubicin—thyroid cancer	0.00055	0.00117	CcSEcCtD
Thiotepa—Pruritus—Sorafenib—thyroid cancer	0.000546	0.00116	CcSEcCtD
Thiotepa—Ataxia—Epirubicin—thyroid cancer	0.000546	0.00116	CcSEcCtD
Thiotepa—Blood creatinine increased—Epirubicin—thyroid cancer	0.000544	0.00116	CcSEcCtD
Thiotepa—Dehydration—Epirubicin—thyroid cancer	0.00054	0.00115	CcSEcCtD
Thiotepa—Diarrhoea—Sorafenib—thyroid cancer	0.000528	0.00113	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000522	0.00111	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000512	0.00109	CcSEcCtD
Thiotepa—Cardiac arrest—Doxorubicin—thyroid cancer	0.00051	0.00109	CcSEcCtD
Thiotepa—Dizziness—Sorafenib—thyroid cancer	0.00051	0.00109	CcSEcCtD
Thiotepa—Ataxia—Doxorubicin—thyroid cancer	0.000505	0.00108	CcSEcCtD
Thiotepa—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000503	0.00107	CcSEcCtD
Thiotepa—Dehydration—Doxorubicin—thyroid cancer	0.000499	0.00107	CcSEcCtD
Thiotepa—Vomiting—Sorafenib—thyroid cancer	0.000491	0.00105	CcSEcCtD
Thiotepa—Rash—Sorafenib—thyroid cancer	0.000487	0.00104	CcSEcCtD
Thiotepa—Dermatitis—Sorafenib—thyroid cancer	0.000486	0.00104	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000483	0.00103	CcSEcCtD
Thiotepa—Headache—Sorafenib—thyroid cancer	0.000483	0.00103	CcSEcCtD
Thiotepa—Pancytopenia—Epirubicin—thyroid cancer	0.000476	0.00102	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000473	0.00101	CcSEcCtD
Thiotepa—Dysuria—Epirubicin—thyroid cancer	0.000469	0.001	CcSEcCtD
Thiotepa—Nausea—Sorafenib—thyroid cancer	0.000458	0.000978	CcSEcCtD
Thiotepa—Weight increased—Epirubicin—thyroid cancer	0.000456	0.000974	CcSEcCtD
Thiotepa—Hyperglycaemia—Epirubicin—thyroid cancer	0.000452	0.000965	CcSEcCtD
Thiotepa—Pneumonia—Epirubicin—thyroid cancer	0.00045	0.00096	CcSEcCtD
Thiotepa—Infestation NOS—Epirubicin—thyroid cancer	0.000447	0.000954	CcSEcCtD
Thiotepa—Infestation—Epirubicin—thyroid cancer	0.000447	0.000954	CcSEcCtD
Thiotepa—Pancytopenia—Doxorubicin—thyroid cancer	0.000441	0.00094	CcSEcCtD
Thiotepa—Renal failure—Epirubicin—thyroid cancer	0.00044	0.000938	CcSEcCtD
Thiotepa—Stomatitis—Epirubicin—thyroid cancer	0.000436	0.00093	CcSEcCtD
Thiotepa—Jaundice—Epirubicin—thyroid cancer	0.000436	0.00093	CcSEcCtD
Thiotepa—Conjunctivitis—Epirubicin—thyroid cancer	0.000435	0.000927	CcSEcCtD
Thiotepa—Dysuria—Doxorubicin—thyroid cancer	0.000434	0.000926	CcSEcCtD
Thiotepa—Haematuria—Epirubicin—thyroid cancer	0.000426	0.00091	CcSEcCtD
Thiotepa—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000423	0.000902	CcSEcCtD
Thiotepa—Weight increased—Doxorubicin—thyroid cancer	0.000422	0.000901	CcSEcCtD
Thiotepa—Epistaxis—Epirubicin—thyroid cancer	0.000422	0.0009	CcSEcCtD
Thiotepa—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000419	0.000893	CcSEcCtD
Thiotepa—Agranulocytosis—Epirubicin—thyroid cancer	0.000417	0.00089	CcSEcCtD
Thiotepa—Pneumonia—Doxorubicin—thyroid cancer	0.000416	0.000888	CcSEcCtD
Thiotepa—Infestation—Doxorubicin—thyroid cancer	0.000414	0.000883	CcSEcCtD
Thiotepa—Infestation NOS—Doxorubicin—thyroid cancer	0.000414	0.000883	CcSEcCtD
Thiotepa—Renal failure—Doxorubicin—thyroid cancer	0.000407	0.000868	CcSEcCtD
Thiotepa—Haemoglobin—Epirubicin—thyroid cancer	0.000403	0.000861	CcSEcCtD
Thiotepa—Jaundice—Doxorubicin—thyroid cancer	0.000403	0.000861	CcSEcCtD
Thiotepa—Stomatitis—Doxorubicin—thyroid cancer	0.000403	0.000861	CcSEcCtD
Thiotepa—Conjunctivitis—Doxorubicin—thyroid cancer	0.000402	0.000858	CcSEcCtD
Thiotepa—Haemorrhage—Epirubicin—thyroid cancer	0.000401	0.000857	CcSEcCtD
Thiotepa—Urinary tract disorder—Epirubicin—thyroid cancer	0.000396	0.000846	CcSEcCtD
Thiotepa—Haematuria—Doxorubicin—thyroid cancer	0.000394	0.000842	CcSEcCtD
Thiotepa—Connective tissue disorder—Epirubicin—thyroid cancer	0.000394	0.000842	CcSEcCtD
Thiotepa—Urethral disorder—Epirubicin—thyroid cancer	0.000393	0.00084	CcSEcCtD
Thiotepa—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000391	0.000835	CcSEcCtD
Thiotepa—Epistaxis—Doxorubicin—thyroid cancer	0.00039	0.000833	CcSEcCtD
Thiotepa—Agranulocytosis—Doxorubicin—thyroid cancer	0.000386	0.000824	CcSEcCtD
Thiotepa—Eye disorder—Epirubicin—thyroid cancer	0.000375	0.0008	CcSEcCtD
Thiotepa—Tinnitus—Epirubicin—thyroid cancer	0.000374	0.000799	CcSEcCtD
Thiotepa—Haemoglobin—Doxorubicin—thyroid cancer	0.000373	0.000797	CcSEcCtD
Thiotepa—Cardiac disorder—Epirubicin—thyroid cancer	0.000373	0.000795	CcSEcCtD
Thiotepa—Haemorrhage—Doxorubicin—thyroid cancer	0.000371	0.000793	CcSEcCtD
Thiotepa—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000367	0.000783	CcSEcCtD
Thiotepa—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000365	0.000779	CcSEcCtD
Thiotepa—Angiopathy—Epirubicin—thyroid cancer	0.000364	0.000777	CcSEcCtD
Thiotepa—Urethral disorder—Doxorubicin—thyroid cancer	0.000364	0.000777	CcSEcCtD
Thiotepa—Immune system disorder—Epirubicin—thyroid cancer	0.000363	0.000774	CcSEcCtD
Thiotepa—Mediastinal disorder—Epirubicin—thyroid cancer	0.000362	0.000772	CcSEcCtD
Thiotepa—Chills—Epirubicin—thyroid cancer	0.00036	0.000769	CcSEcCtD
Thiotepa—Arrhythmia—Epirubicin—thyroid cancer	0.000359	0.000765	CcSEcCtD
Thiotepa—Alopecia—Epirubicin—thyroid cancer	0.000355	0.000757	CcSEcCtD
Thiotepa—Mental disorder—Epirubicin—thyroid cancer	0.000352	0.00075	CcSEcCtD
Thiotepa—Erythema—Epirubicin—thyroid cancer	0.000349	0.000746	CcSEcCtD
Thiotepa—Malnutrition—Epirubicin—thyroid cancer	0.000349	0.000746	CcSEcCtD
Thiotepa—Eye disorder—Doxorubicin—thyroid cancer	0.000347	0.000741	CcSEcCtD
Thiotepa—Tinnitus—Doxorubicin—thyroid cancer	0.000346	0.000739	CcSEcCtD
Thiotepa—Cardiac disorder—Doxorubicin—thyroid cancer	0.000345	0.000736	CcSEcCtD
Thiotepa—Tension—Epirubicin—thyroid cancer	0.000343	0.000732	CcSEcCtD
Thiotepa—Nervousness—Epirubicin—thyroid cancer	0.000339	0.000724	CcSEcCtD
Thiotepa—Back pain—Epirubicin—thyroid cancer	0.000338	0.000721	CcSEcCtD
Thiotepa—Angiopathy—Doxorubicin—thyroid cancer	0.000337	0.000719	CcSEcCtD
Thiotepa—Immune system disorder—Doxorubicin—thyroid cancer	0.000335	0.000716	CcSEcCtD
Thiotepa—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000335	0.000714	CcSEcCtD
Thiotepa—Chills—Doxorubicin—thyroid cancer	0.000333	0.000711	CcSEcCtD
Thiotepa—Arrhythmia—Doxorubicin—thyroid cancer	0.000332	0.000708	CcSEcCtD
Thiotepa—Vision blurred—Epirubicin—thyroid cancer	0.000329	0.000703	CcSEcCtD
Thiotepa—Alopecia—Doxorubicin—thyroid cancer	0.000328	0.0007	CcSEcCtD
Thiotepa—Mental disorder—Doxorubicin—thyroid cancer	0.000325	0.000694	CcSEcCtD
Thiotepa—Malnutrition—Doxorubicin—thyroid cancer	0.000323	0.00069	CcSEcCtD
Thiotepa—Erythema—Doxorubicin—thyroid cancer	0.000323	0.00069	CcSEcCtD
Thiotepa—Anaemia—Epirubicin—thyroid cancer	0.000323	0.000689	CcSEcCtD
Thiotepa—Agitation—Epirubicin—thyroid cancer	0.000321	0.000685	CcSEcCtD
Thiotepa—Tension—Doxorubicin—thyroid cancer	0.000317	0.000677	CcSEcCtD
Thiotepa—Nervousness—Doxorubicin—thyroid cancer	0.000314	0.00067	CcSEcCtD
Thiotepa—Leukopenia—Epirubicin—thyroid cancer	0.000313	0.000667	CcSEcCtD
Thiotepa—Back pain—Doxorubicin—thyroid cancer	0.000313	0.000667	CcSEcCtD
Thiotepa—Cough—Epirubicin—thyroid cancer	0.000305	0.000651	CcSEcCtD
Thiotepa—Vision blurred—Doxorubicin—thyroid cancer	0.000305	0.00065	CcSEcCtD
Thiotepa—Convulsion—Epirubicin—thyroid cancer	0.000303	0.000646	CcSEcCtD
Thiotepa—Hypertension—Epirubicin—thyroid cancer	0.000302	0.000644	CcSEcCtD
Thiotepa—Anaemia—Doxorubicin—thyroid cancer	0.000299	0.000638	CcSEcCtD
Thiotepa—Arthralgia—Epirubicin—thyroid cancer	0.000297	0.000635	CcSEcCtD
Thiotepa—Myalgia—Epirubicin—thyroid cancer	0.000297	0.000635	CcSEcCtD
Thiotepa—Agitation—Doxorubicin—thyroid cancer	0.000297	0.000634	CcSEcCtD
Thiotepa—Anxiety—Epirubicin—thyroid cancer	0.000296	0.000633	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000295	0.00063	CcSEcCtD
Thiotepa—Leukopenia—Doxorubicin—thyroid cancer	0.000289	0.000618	CcSEcCtD
Thiotepa—Confusional state—Epirubicin—thyroid cancer	0.000288	0.000614	CcSEcCtD
Thiotepa—Infection—Epirubicin—thyroid cancer	0.000283	0.000605	CcSEcCtD
Thiotepa—Cough—Doxorubicin—thyroid cancer	0.000282	0.000602	CcSEcCtD
Thiotepa—Convulsion—Doxorubicin—thyroid cancer	0.00028	0.000598	CcSEcCtD
Thiotepa—Nervous system disorder—Epirubicin—thyroid cancer	0.00028	0.000597	CcSEcCtD
Thiotepa—Thrombocytopenia—Epirubicin—thyroid cancer	0.000279	0.000596	CcSEcCtD
Thiotepa—Hypertension—Doxorubicin—thyroid cancer	0.000279	0.000596	CcSEcCtD
Thiotepa—Tachycardia—Epirubicin—thyroid cancer	0.000278	0.000594	CcSEcCtD
Thiotepa—Skin disorder—Epirubicin—thyroid cancer	0.000277	0.000591	CcSEcCtD
Thiotepa—Arthralgia—Doxorubicin—thyroid cancer	0.000275	0.000587	CcSEcCtD
Thiotepa—Myalgia—Doxorubicin—thyroid cancer	0.000275	0.000587	CcSEcCtD
Thiotepa—Anxiety—Doxorubicin—thyroid cancer	0.000274	0.000585	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000273	0.000583	CcSEcCtD
Thiotepa—Anorexia—Epirubicin—thyroid cancer	0.000272	0.00058	CcSEcCtD
Thiotepa—Confusional state—Doxorubicin—thyroid cancer	0.000266	0.000568	CcSEcCtD
Thiotepa—Infection—Doxorubicin—thyroid cancer	0.000262	0.000559	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00026	0.000554	CcSEcCtD
Thiotepa—Nervous system disorder—Doxorubicin—thyroid cancer	0.000259	0.000552	CcSEcCtD
Thiotepa—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000258	0.000551	CcSEcCtD
Thiotepa—Tachycardia—Doxorubicin—thyroid cancer	0.000258	0.00055	CcSEcCtD
Thiotepa—Skin disorder—Doxorubicin—thyroid cancer	0.000256	0.000547	CcSEcCtD
Thiotepa—Paraesthesia—Epirubicin—thyroid cancer	0.000256	0.000546	CcSEcCtD
Thiotepa—Somnolence—Epirubicin—thyroid cancer	0.000254	0.000541	CcSEcCtD
Thiotepa—Anorexia—Doxorubicin—thyroid cancer	0.000252	0.000537	CcSEcCtD
Thiotepa—Dyspepsia—Epirubicin—thyroid cancer	0.000251	0.000536	CcSEcCtD
Thiotepa—Decreased appetite—Epirubicin—thyroid cancer	0.000248	0.000529	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000246	0.000525	CcSEcCtD
Thiotepa—Fatigue—Epirubicin—thyroid cancer	0.000246	0.000525	CcSEcCtD
Thiotepa—Pain—Epirubicin—thyroid cancer	0.000244	0.00052	CcSEcCtD
Thiotepa—Constipation—Epirubicin—thyroid cancer	0.000244	0.00052	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00024	0.000513	CcSEcCtD
Thiotepa—Paraesthesia—Doxorubicin—thyroid cancer	0.000237	0.000506	CcSEcCtD
Thiotepa—Feeling abnormal—Epirubicin—thyroid cancer	0.000235	0.000501	CcSEcCtD
Thiotepa—Somnolence—Doxorubicin—thyroid cancer	0.000235	0.000501	CcSEcCtD
Thiotepa—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000233	0.000498	CcSEcCtD
Thiotepa—Dyspepsia—Doxorubicin—thyroid cancer	0.000232	0.000496	CcSEcCtD
Thiotepa—Decreased appetite—Doxorubicin—thyroid cancer	0.000229	0.000489	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000228	0.000486	CcSEcCtD
Thiotepa—Fatigue—Doxorubicin—thyroid cancer	0.000227	0.000485	CcSEcCtD
Thiotepa—Urticaria—Epirubicin—thyroid cancer	0.000227	0.000483	CcSEcCtD
Thiotepa—Pain—Doxorubicin—thyroid cancer	0.000226	0.000481	CcSEcCtD
Thiotepa—Constipation—Doxorubicin—thyroid cancer	0.000226	0.000481	CcSEcCtD
Thiotepa—Abdominal pain—Epirubicin—thyroid cancer	0.000225	0.000481	CcSEcCtD
Thiotepa—Body temperature increased—Epirubicin—thyroid cancer	0.000225	0.000481	CcSEcCtD
Thiotepa—Feeling abnormal—Doxorubicin—thyroid cancer	0.000217	0.000464	CcSEcCtD
Thiotepa—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000216	0.00046	CcSEcCtD
Thiotepa—Hypersensitivity—Epirubicin—thyroid cancer	0.00021	0.000448	CcSEcCtD
Thiotepa—Urticaria—Doxorubicin—thyroid cancer	0.00021	0.000447	CcSEcCtD
Thiotepa—Abdominal pain—Doxorubicin—thyroid cancer	0.000209	0.000445	CcSEcCtD
Thiotepa—Body temperature increased—Doxorubicin—thyroid cancer	0.000209	0.000445	CcSEcCtD
Thiotepa—Asthenia—Epirubicin—thyroid cancer	0.000205	0.000437	CcSEcCtD
Thiotepa—Pruritus—Epirubicin—thyroid cancer	0.000202	0.000431	CcSEcCtD
Thiotepa—Diarrhoea—Epirubicin—thyroid cancer	0.000195	0.000416	CcSEcCtD
Thiotepa—Hypersensitivity—Doxorubicin—thyroid cancer	0.000194	0.000415	CcSEcCtD
Thiotepa—Asthenia—Doxorubicin—thyroid cancer	0.000189	0.000404	CcSEcCtD
Thiotepa—Dizziness—Epirubicin—thyroid cancer	0.000189	0.000402	CcSEcCtD
Thiotepa—Pruritus—Doxorubicin—thyroid cancer	0.000187	0.000398	CcSEcCtD
Thiotepa—Vomiting—Epirubicin—thyroid cancer	0.000181	0.000387	CcSEcCtD
Thiotepa—Diarrhoea—Doxorubicin—thyroid cancer	0.000181	0.000385	CcSEcCtD
Thiotepa—Rash—Epirubicin—thyroid cancer	0.00018	0.000384	CcSEcCtD
Thiotepa—Dermatitis—Epirubicin—thyroid cancer	0.00018	0.000383	CcSEcCtD
Thiotepa—Headache—Epirubicin—thyroid cancer	0.000179	0.000381	CcSEcCtD
Thiotepa—Dizziness—Doxorubicin—thyroid cancer	0.000174	0.000372	CcSEcCtD
Thiotepa—Nausea—Epirubicin—thyroid cancer	0.000169	0.000361	CcSEcCtD
Thiotepa—Vomiting—Doxorubicin—thyroid cancer	0.000168	0.000358	CcSEcCtD
Thiotepa—Rash—Doxorubicin—thyroid cancer	0.000166	0.000355	CcSEcCtD
Thiotepa—Dermatitis—Doxorubicin—thyroid cancer	0.000166	0.000355	CcSEcCtD
Thiotepa—Headache—Doxorubicin—thyroid cancer	0.000165	0.000353	CcSEcCtD
Thiotepa—Nausea—Doxorubicin—thyroid cancer	0.000157	0.000334	CcSEcCtD
